2012
DOI: 10.1016/j.tube.2012.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Point-of-care breath test for biomarkers of active pulmonary tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
132
0
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 155 publications
(142 citation statements)
references
References 29 publications
2
132
0
2
Order By: Relevance
“…Notably, M. tuberculosis-associated breath volatile metabolites detected in active pulmonary TB were structurally similar but not identical to those generated from in vitro cultures (73). The results suggest the feasibility of distinguishing active pulmonary TB from nonactive TB by breath VOC patterns.…”
Section: Respiratory Infectionsmentioning
confidence: 79%
See 3 more Smart Citations
“…Notably, M. tuberculosis-associated breath volatile metabolites detected in active pulmonary TB were structurally similar but not identical to those generated from in vitro cultures (73). The results suggest the feasibility of distinguishing active pulmonary TB from nonactive TB by breath VOC patterns.…”
Section: Respiratory Infectionsmentioning
confidence: 79%
“…The second approach, which is based upon a combination of pathogen-specific biomarkers and those generated in vivo during reciprocal host-pathogen interactions, has been successfully utilized for TB detection (71)(72)(73). In the clinical studies described above, results of potential clinical value have been reported by Michael Phillips and coworkers, who evaluated the performance of TB-related breath VOC profiles on a large number of TB patients by using a convenient POC system (72,73). However, monitoring of changes/alterations in these biomarkers during treatment and their prognostic significance remain to be evaluated.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…EU supported TMREST consortium is involved in a newly developed integrated Lab-on-Chip versatile platform for fast detection of MDR [31]. Handful of leading chemists are busy deciphering the pattern recognition of volatile organic compounds in breath or other body fluids to be able to develop electronic nose for TB [32,33].…”
Section: New Tools In the Horizonmentioning
confidence: 99%